Global Analgesics Market 2016-2020
- Published: Jun 2016
- Pages: 102
- SKU: IRTNTR9551
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This market research study presents a detailed analysis of the market shares for key vendors including Pfizer, Bayer HealthCare, Sanofi, Endo, Johnson & Johnson, and Purdue Pharma. It also presents a detailed analysis of the global analgesics market by drug class, by type, by application, by pain type, by ROA, and by geography.
Global analgesics market forecast
According to the analgesics market statistics, the global analgesics market is envisaged to grow steadily and will post a CAGR of more than 4% over the forecast period. The advent of favorable regulatory norms and healthcare reforms around the world have encouraged the initiation and uptake of pain management programs to reduce the overall healthcare costs. For instance, the US Patient Protection and Affordable Care Act has provision for pain management. Such healthcare reforms have paved the way toward the development of effective analgesic medications. This recent increase in the introduction of favorable regulatory norms will lead to the augmented adoption of analgesics and will increase the analgesics market size in the coming years.
The increasing use of off-label drugs is one of the significant trends spurring the growth prospects of this market over the forecast period. Off-label drugs are unapproved medications that are effective in treating diseases. Several off-label drugs, such as tricyclic antidepressants, selective serotonin reuptake inhibitors, antihistamines, anti-anxiety drugs, anticonvulsants, steroids, and analgesics are being increasingly used to manage the symptoms of pain. These drugs are prescribed with approved drugs as maintenance therapies. Moreover, since these drugs are less expensive than approved drugs, it will contribute to this market’s growth over the next four years.
Segmentation by type and analysis of the analgesics market
- Prescription analgesics
- OTC analgesics
The prescription analgesics segment dominated the market and accounted for a market share of more than 52% over the forecast period. The growth of this market is attributed to the growing popularity of generics for pain management. Apart from their affordability, the rising number of individuals requiring analgesics and the widening distribution channels will propel the growth prospects for this segment by 2020.
Geographical segmentation and analysis of the analgesics market
- Americas
- APAC
- EMEA
In terms of geography, the Americas led the global analgesics market and is anticipated to reach more than USD 18 billion by 2020. The rising prevalence of osteoarthritis is one of the most important drivers propelling this market’s growth in the Americas. Moreover, better access to healthcare services and various initiatives by the government to improve the healthcare infrastructure in the country will aid in the growth of this market in this region.
Competitive landscape and key vendors
The global analgesics market is highly fragmented owing to the presence of several small and large vendors. Due to the influx of new vendors, the level of competition is likely to intensify over the forecast period. Players in the market are constantly looking for ways to enhance their market presence by focusing on the implementation of various new business models and M&A activities.
Key vendors in this market are
- Pfizer
- Bayer HealthCare
- Sanofi
- Endo
- Johnson & Johnson
- Purdue Pharma
Other prominent vendors in the market are Achelios Therapeutics, Alder BioPharmaceuticals, Allergan, Amgen, AstraZeneca plc, Baxter, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, CoLucid Pharmaceuticals, Daiichi Sankyo Company, Dr. Reddy's Laboratories, DURECT Corporation, El Lilly & Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, GW Pharmaceuticals, Hospira, Immune Pharmaceuticals, Innovative Med Concepts LLC, Merck, NeurAxon, Novartis AG, OptiNose, Pain Therapeutics, RedHill, Sorrento Therapeutics, Suda, Taro Pharmaceuticals Industries, Teva Pharmaceuticals Industries, Tonix Pharmaceuticals Holding, Trigemina, UCB SA, Valeant Pharmaceuticals International, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the global analgesics market?
- What are the key market trends impacting the growth of the global analgesics market?
- What are the challenges to market growth?
- Who are the key vendors in the global analgesics market?
- What are the market opportunities and threats faced by the vendors in the global analgesics market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global analgesics market?
Technavio also offers customization on reports based on specific client requirement.
Related reports:
Table of Contents
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Assumptions
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
- Pain: Overview
PART 05: Pipeline portfolio
- Information on pipeline candidates
PART 06: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 07: Market segmentation by drug class
- Opioids
- NSAIDs
- Other
- Global opioids market
- Global NSAIDs Market
PART 08: Market segmentation by type
- Prescription analgesics
- OTC analgesics
PART 09: Market segmentation by application
- Global internal analgesics market
- Global external analgesics market
PART 10: Market segmentation by pain type
- Musculoskeletal pain
- Surgical and trauma pain
- Cancer pain
- Neuropathic pain
- Migraine
- Obstetrical pain
Fibromyalgia
- Pain due to burns
- Dental/facial pain
- Pediatric pain
PART 11: Market segmentation by ROA
- Oral
- Parenteral
- Topical
- Transdermal
- Rectal
PART 12: Geographical segmentation
- Analgesics market in Americas
- Analgesics market in EMEA
- Analgesics market in APAC
PART 13: Market drivers
- Growing geriatric population
- Increase in self-medication
- Promising pipeline
- Favorable regulatory scenario
PART 14: Impact of drivers
PART 15: Market challenges
- Generic competition
- Preference for alternative therapies
- Counterfeit pharmaceuticals
PART 16: Impact of drivers and challenges
PART 17: Market trends
- Accelerated use of online resources
- Increase in R&D
- Off-label drugs use
- Strategic alliances
PART 18: Vendor landscape
- Competitive scenario
- Market share analysis 2015
- Pfizer
- Bayer Healthcare
- Sanofi
- Endo International
- Johnson & Johnson
- Purdue Pharma
- Other prominent vendors
PART 19: Appendix
- List of abbreviations
PART 20: Explore Technavio
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
